financetom
Business
financetom
/
Business
/
Exclusive-LVMH explores sale of its 50% stake in Rihanna-backed Fenty Beauty, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-LVMH explores sale of its 50% stake in Rihanna-backed Fenty Beauty, sources say
Oct 21, 2025 2:48 PM

(Reuters) -Luxury goods giant LVMH is exploring a sale of its 50% stake in Fenty Beauty, which it co-owns with Grammy Award-winning singer and entrepreneur Rihanna, according to four people familiar with the matter.

The company is working with investment bank Evercore on the sale, three of the people said. All four asked not to be identified because the process is confidential.

In 2017, Rihanna, whose full name is Robyn Rihanna Fenty, launched Fenty Beauty with the help of Kendo Brands, LVMH's in-house beauty incubator. She and LVMH each own half of the company, sources said.

LVMH and Evercore declined to comment. Fenty Beauty and representatives for Rihanna did not immediately return requests for comment.

Fenty Beauty, which generated around $450 million of net sales in 2024, could be valued at somewhere between $1 billion to $2 billion, two of the people said.

Barbados-born Rihanna, who also owns lingerie brand Savage X Fenty, started Fenty Beauty to create a makeup line that works for a wider range of skin tones and types, including Black, Hispanic and Asian women. The products, which include makeup, skincare, haircare and fragrance, are sold in Sephora and on Amazon.

Elf Beauty bought Hailey Bieber's company Rhode for $1 billion earlier this year. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie Closes Aliada Therapeutics Acquisition
AbbVie Closes Aliada Therapeutics Acquisition
Dec 11, 2024
09:37 AM EST, 12/11/2024 (MT Newswires) -- AbbVie ( ABBV ) said Wednesday it has closed the acquisition of Aliada Therapeutics. The company in October agreed to acquire Aliada Therapeutics for $1.40 billion in cash. Price: 174.85, Change: -0.82, Percent Change: -0.47 ...
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Dec 11, 2024
09:34 AM EST, 12/11/2024 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Wednesday it has bought Georgia-based employee benefits brokerage firm Sheila J. Butler & Co. Financial terms weren't disclosed. Price: 284.17, Change: +0.43, Percent Change: +0.15 ...
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
Dec 11, 2024
On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...
Evergold's DEM Prospect Returns High Grades of Antimony in Drilling; Shares down 12%
Evergold's DEM Prospect Returns High Grades of Antimony in Drilling; Shares down 12%
Dec 11, 2024
09:39 AM EST, 12/11/2024 (MT Newswires) -- Evergold ( EVGUF ) on Wednesday announced assay results for two core holes (DEM24-04 and DEM24-05) completed on the DEM Mountain Zone near Fort St. James, B.C. in early Oct., in follow up to highly encouraging results from an initial 3-hole drill program (DEM23-01,02,03), carried out in fall 2023. The company said the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved